Dataciencia

Colección SciELO Chile

The SMARTscreen Trial: a randomised controlled trial investigating the efficacy of a GP-endorsed narrative SMS to increase participation in the Australian National Bowel Cancer Screening Program

Indexado

WoS	WOS:000741996500003
Scopus	SCOPUS_ID:85122971412

DOI

10.1186/S13063-021-05877-3

Año

2022

Tipo

artículo de investigación

Citas Totales

Autores Afiliación Chile

Instituciones Chile

% Participación
Internacional

Autores
Afiliación Extranjera

Instituciones
Extranjeras

Abstract

Discussion: This efficacy trial will provide initial trial evidence of the utility of an SMS narrative intervention to increase participation in the NBCSP. The results will inform decisions about the need for and design of a larger, multi-state trial of this SMS intervention to determine its cost-effectiveness and future implementation.

Revista

Revista	ISSN
Trials	1745-6215

Métricas Externas

PlumX	Altmetric	Dimensions

Muestra métricas de impacto externas asociadas a la publicación. Para mayor detalle:

Plumx: https://plumanalytics.com/learn/about-metrics/
Altmetric: https://www.altmetric.com/about-altmetrics/what-are-altmetrics/
Dimensions: https://www.dimensions.ai/why-dimensions/

Disciplinas de Investigación

WOS
Medicine, Research & Experimental

Scopus
Medicine (Miscellaneous)
Pharmacology (Medical)

SciELO
Sin Disciplinas

Muestra la distribución de disciplinas para esta publicación.

Publicaciones WoS (Ediciones: ISSHP, ISTP, AHCI, SSCI, SCI), Scopus, SciELO Chile.

Colaboración Institucional

Muestra la distribución de colaboración, tanto nacional como extranjera, generada en esta publicación.

Autores - Afiliación

Ord.	Autor	Género	Institución - País
1	Wood, Anna	Mujer	Univ Melbourne - Australia University of Melbourne - Australia
2	Emery, Jon	Hombre	Univ Melbourne - Australia University of Melbourne - Australia
3	Jenkins, Mark A.	Hombre	Univ Melbourne - Australia Melbourne School of Population and Global Health - Australia University of Melbourne - Australia
4	Chondros, Patty	Mujer	Univ Melbourne - Australia University of Melbourne - Australia
5	Campbell, Tina	Mujer	Healthily Pty Ltd - Australia
6	Wenkart, Edweana	-	Pen Comp Syst - Australia Pen Computer Systems - Australia
7	O'Reilly, Clare	Mujer	Canc Council Victoria - Australia Cancer Council Victoria - Australia
8	Cowie, Tony	Hombre	Canc Council Victoria - Australia Cancer Council Victoria - Australia
9	Dixon, Ian	-	Healthily Pty Ltd - Australia
10	Toner, Julie	Mujer	Healthily Pty Ltd - Australia
11	Khalajzadeh, Hourieh	-	MONASH UNIV - Australia Monash University - Australia
12	Gutierrez, Javiera	Mujer	Univ Melbourne - Australia Pontificia Universidad Católica de Chile - Chile University of Melbourne - Australia
13	Govan, Linda	Mujer	Western Victoria Primary Hlth Network Ltd - Australia Western Victoria Primary Health Network Ltd - Australia Western Victorian Primary Health Network - Australia
14	Buckle, Gemma	Mujer	Pen Comp Syst - Australia Pen Computer Systems - Australia
15	McIntosh, Jennifer	Mujer	Univ Melbourne - Australia MONASH UNIV - Australia University of Melbourne - Australia Monash University - Australia

Muestra la afiliación y género (detectado) para los co-autores de la publicación.

Financiamiento

Fuente
Australian Research Council
National Health and Medical Research Council
Cancer Research UK
NHMRC
Cancer Council Victoria
Victorian Cancer Agency
CanTest collaborative grant (Cancer Research UK)
Victorian Cancer Agency project grant

Muestra la fuente de financiamiento declarada en la publicación.

Agradecimientos

Agradecimiento
SMARTscreen is funded by the Victorian Cancer Agency project grant (CPRS RG19018). JE and MJ are supported by NHMRC Investigator Fellowships. JM and HK are supported by Professor John Grundy's Australian Research Council Laureate Fellowship (FL190100035). JMG is supported by CanTest collaborative grant (Cancer Research UK C8640/A23385).
The authors acknowledge the following for their support and contribution to this trial. Participating general practice staff, especially practice managers and practice nurses who have supported and championed the trial in their general practice. The Western Victorian Primary Health Network (WVPHN), Cancer Council Victoria, the staff at Pen CS and Healthily, in particular, Lyle Innes, Neil Roberts and Matthias Merzenich. This trial is supported by the Primary Care Collaborative Cancer Clinical Trials Group (PC4).

Agradecimiento

SMARTscreen is funded by the Victorian Cancer Agency project grant (CPRS RG19018). JE and MJ are supported by NHMRC Investigator Fellowships. JM and HK are supported by Professor John Grundy's Australian Research Council Laureate Fellowship (FL190100035). JMG is supported by CanTest collaborative grant (Cancer Research UK C8640/A23385).

The authors acknowledge the following for their support and contribution to this trial. Participating general practice staff, especially practice managers and practice nurses who have supported and championed the trial in their general practice. The Western Victorian Primary Health Network (WVPHN), Cancer Council Victoria, the staff at Pen CS and Healthily, in particular, Lyle Innes, Neil Roberts and Matthias Merzenich. This trial is supported by the Primary Care Collaborative Cancer Clinical Trials Group (PC4).